We retrospectively analyzed patients undergoing RRH and LRH, performing a 1:1 PSM based on preoperative characteristics. Postoperative outcomes were compared, and significant predictors of textbook ...
A Japanese retrospective cohort linked daily ward rosters with 77,289 admissions (median age 69.3 years; 53.2% surgical) to evaluate mortality, 7–30-day readmissions, and length of stay. Understaffing ...
Three-dimensional virtual models (3DVMs) have emerged as a promising tool to enhance both surgical precision and functional outcomes in complex robot-assisted partial nephrectomies (RAPN). This study ...
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be ...
Background and Objectives: Flow diverters (FDs) have been increasingly used in treating unruptured intracranial aneurysms (UIAs). However, comparative studies between the novel Lattice Flow Diverter ...
Colon cancer patients with elevated B12 levels had a median overall survival of 59.4 months, compared to 129.8 months for patients with normal B12 levels. Researchers have identified an elevated ...
The holidays are a magical time, filled with sparkling lights, the smell of pine, and, most importantly, the warmth of family memories. But let’s be honest: the best memories often happen not in the ...
ABSTRACT: Special education services are designed to provide tailored support for students with diverse learning needs, with the expectation of improving academic achievement. This study examines the ...
ABSTRACT: Special education services are designed to provide tailored support for students with diverse learning needs, with the expectation of improving academic achievement. This study examines the ...
Early stroke recurrence is a significant risk for survivors of ischemic stroke. Although admission severity is commonly used in prognosis, the predictive value of residual neurological deficits at ...
Background Middle meningeal artery embolization (MMAE) is a promising treatment for non-acute subdural hematoma (NASDH), but trial evidence is limited by heterogeneity and open label design bias. This ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results